首页> 外文期刊>AMB Express >Synergistic interaction of eugenol and antimicrobial drugs in eradication of single and mixed biofilms of Candida albicans and Streptococcus mutans
【24h】

Synergistic interaction of eugenol and antimicrobial drugs in eradication of single and mixed biofilms of Candida albicans and Streptococcus mutans

机译:丁香酚和抗菌药物在根除念珠菌和链球菌的混合生物膜中的协同相互作用

获取原文
获取外文期刊封面目录资料

摘要

In vitro eradication of the C. albicans and S. mutans mixed biofilms by eugenol alone and in combination with the antimicrobial drugs. Previously characterized strains of C. albicans (CAJ-01 and CAJ-12) and S. mutans MTCC497 were used to evaluate the eradication of biofilms using XTT reduction assay, viability assay, time dependent killing assay and scanning electron microscopy (SEM). Synergistic interaction was assessed by checkerboard method. Sessile MIC (SMIC) of eugenol was equivalent to the planktonic MIC (PMIC) against C. albicans and S. mutans mixed biofilms. SMIC of fluconazole and azithromycin was increased upto 1000-folds over PMIC. Eradication of single or mixed biofilms was evident from the viability assay and SEM. At 1?×?MIC of eugenol, log10CFU count of C. albicans cells were decreased from 6.3 to 4.2 and 3.8 (p?&?0.05) in single and mixed biofilms, respectively. SEM studies revealed the eradication of C. albicans and S. mutans cells from glass surface at 800?μg/mL concentration of eugenol. Time dependent killing assay showed dose dependent effect of eugenol on pre-formed CAJ-01, CAJ-12 and S. mutans biofilm cells. Eugenol was highly synergistic with fluconazole (FICI?=?0.156) against CAJ-12 single biofilms. However, the combination of eugenol and azithromycin showed maximum synergy (FICI?=?0.140) against pre-formed C. albicans and S. mutans mixed biofilms. These findings highlighted the promising efficacy of eugenol in the eradication of biofilms of two oral pathogens (C. albicans and S. mutans) in vitro and could also be exploited in synergy with fluconazole and azithromycin in controlling oral infections.
机译:单独使用丁香酚并与抗微生物药物组合使用丁香酚的C. albicans和S. mutans混合生物膜。以前表征的C. albicans(CAJ-01和CAJ-12)和S.Ulans MTCC497的菌株用于评估使用XTT降低测定,活力测定,时间依赖性杀死测定和扫描电子显微镜(SEM)的消除生物膜。通过棋盘方法评估协同互动。丁香酚的术术麦克风(SMIC)相当于氏菌菌(PMIC)对抗C. albicans和S. mutans混合生物膜。氟康唑和四胞菌霉素的SMIC在PMIC上增加了1000倍。从活力测定和SEM中消除单一或混合生物膜。在1?××βmOugenol的MIC中,C. albicans细胞的log10CFU计数分别在单一和混合生物膜中从6.3-4.2和3.8(p≤≤0.05)降低。 SEM研究表明,在800〜μg/ mL浓度的丁香酚中,从玻璃表面消除C.醛糖苷和S。时间依赖性杀死测定显示丁香酚对预形成的CAJ-01,CAJ-12和S. mutans生物膜细胞的剂量依赖性作用。丁烯醇与氟康唑(Fici?= 0.156)对Caj-12单一生物膜的高度协同作用。然而,丁香酚和阿奇霉素的组合对预形成的C. albicans和S. mutans混合生物膜显示出最大的协同作用(Fici?= 0.140)。这些发现突出了丁香酚在体外消除两种口服病原体(C. albicans和S. mutans)的生物膜中的有希望的疗效,并且也可以在控制口腔感染方面与氟康唑和阿奇霉素的协同作用中被利用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号